Lumenis Ltd. Archives - Medical Design Sourcing

Boston Scientific completes $1.1B Lumenis acquisition

Boston Scientific (NYSE:BSX) announced today that it completed the nearly $1.1 billion acquisition of the global surgical business of Lumenis.

Marlborough, Massachusetts-based Boston Scientific announced in March that it entered into a definitive agreement with an affiliate of Baring Private Equity Asia (BPEA) to acquire Lumenis’ surgical business, which develops and commercializes energy-based medical solutions. The deal includes an upfront cash payment of $1.07 billion, subject to closing adjustments, according to that previous announcement.

In a news release, Boston Scientific said that Lumenis’ surgical business, which includes premier laser systems, fibers and accessories for urology and otolaryngology procedures, expects to bring in revenues around approximately $200 million across 2021.

The two companies have held a relationship for over 20 years, with Boston Scientific already offering the Lumenis urology laser portfolio in the U.S. a…

DTW Podcast: Can AI, advanced imaging and robotics “democratize” surgery?

A new generation of digital surgery systems will level the playing field for surgeons giving them artificial intelligence, robotic tools and other assistive technologies.

In three interviews in this week’s DeviceTalks Weekly Podcast, leaders form Asensus, ActivSurgical and Memic explain how their systems will improve surgeon performance, reduce errors, and deliver the “democratization” of surgical robotics.

Guests this week include

Anthony Fernando, CEO of Asensus Surgical (formerly Transenterix), outlines the company’s bid to push its Sehance system as a solution for laparoscopic procedures. Fernando, who took over as CEO in 2019, explains why the company’s stock crashed in 2019 and details the changes that he says has started the company’s turnaround. Senhance offers more responsive surgical tools along with data that will help with surgical training and scheduling.

Todd Usen, CEO of ActivSurgical, left a job he loved at Olympus to lead a compan…

Boston Scientific to acquire Lumenis surgical business for $1.07B

Boston Scientific (NYSE:BSX) announced today that it entered into a definitive agreement to acquire the global surgical business of Lumenis for nearly $1.1 billion.

Marlborough, Mass.-based Boston Scientific entered into the agreement with an affiliate of Baring Private Equity Asia (BPEA) to acquire the global surgical business of the privately-held company developing and commercializing energy-based medical solutions. The deal includes an upfront cash payment of $1.07 billion, subject to closing adjustments, according to a news release.

BPEA is slated to retain ownership of the Lumenis global aesthetics and ophthalmology businesses, while Boston Scientific picks up a surgical business expected to bring in 2021 revenues of approximately $200 million. The company expects the deal to be completed in the second half of 2021, with an immaterial impact on adjusted earnings per share this year. EPS impact is expected to be 2¢ accretive in 2022 and increasingly accret…